Hikma Pharmaceuticals Plc Annual Information Update (6906B)
April 05 2013 - 6:03AM
UK Regulatory
TIDMHIK
RNS Number : 6906B
Hikma Pharmaceuticals Plc
05 April 2013
Annual Information Update
London, 5 April 2013. In accordance with Prospectus Rule 5.2,
Hikma Pharmaceuticals PLC ("Hikma" or "the Company") (LSE: HIK)
sets out below a summary of the information which has been
published or made available to the public over the period. The
information referred to in this Update was up to date at the time
the information was published, but some information may now be out
of date.
Stock Exchange Announcements
Announcements made by the Company via RNS, a Regulatory
Information Service, may be viewed and downloaded from the
Company's market news section on the London Stock Exchange website
at
(http://www.londonstockexchange.com/prices-and-news/stocks/stocks-and-prices.htm)
or from the press releases page on the Company's website at
(http://www.hikma.com/investorrelations/rns/). The Stock Exchange
announcements made during the period were:
Date Headline
----------- ------------------------------------------------
25/03/2013 Director/PDMR Shareholding
----------- ------------------------------------------------
13/03/2013 Preliminary Results
----------- ------------------------------------------------
01/03/2013 Response to unsolicited enquiries
----------- ------------------------------------------------
21/01/2013 Additional Listing
----------- ------------------------------------------------
09/01/2013 Acquisition
----------- ------------------------------------------------
03/01/2013 Total Voting Rights
----------- ------------------------------------------------
27/12/2012 Holding(s) in Company
----------- ------------------------------------------------
13/12/2012 Product Launch
----------- ------------------------------------------------
27/11/2012 Building Public Trust Awards - Highly Commended
----------- ------------------------------------------------
12/11/2012 Total Voting Rights
----------- ------------------------------------------------
02/11/2012 Interim Management Statement
----------- ------------------------------------------------
01/11/2012 Holding(s) in Company
----------- ------------------------------------------------
11/10/2012 Injectables Analyst and Investor Day USA
----------- ------------------------------------------------
10/10/2012 Blocklisting Interim Review
----------- ------------------------------------------------
10/10/2012 Total Voting Rights
----------- ------------------------------------------------
04/10/2012 Dividend Declaration
----------- ------------------------------------------------
16/08/2012 Half Yearly Report
----------- ------------------------------------------------
08/08/2012 Holding(s) in Company
----------- ------------------------------------------------
06/07/2012 Total Voting Rights
----------- ------------------------------------------------
03/07/2012 Holding(s) in Company
----------- ------------------------------------------------
29/06/2012 Director/PDMR Shareholding
----------- ------------------------------------------------
25/06/2012 Director/PDMR Shareholding
----------- ------------------------------------------------
21/06/2012 Director/PDMR Shareholding
----------- ------------------------------------------------
06/06/2012 Total Voting Rights
----------- ------------------------------------------------
18/05/2012 Director/PDMR Shareholding
----------- ------------------------------------------------
17/05/2012 Result of AGM
----------- ------------------------------------------------
17/05/2012 Interim Management Statement
----------- ------------------------------------------------
01/05/2012 Holding(s) in Company
----------- ------------------------------------------------
20/04/2012 Holding(s) in Company
----------- ------------------------------------------------
16/04/2012 Annual Information Update
----------- ------------------------------------------------
13/04/2012 Annual Financial Report & AGM Notice
----------- ------------------------------------------------
All of the above announcements were also made by the Company via
the Nasdaq Dubai stock exchange CANDI system. These announcements
may be viewed and downloaded from the Nasdaq Dubai website
(www.candi.nasdaq.com).
Documents filed with the Financial Services Authority
The Company has filed the following documents with the Financial
Services Authority ("FSA") visa the National Storage Mechanism over
the previous 12 months. These documents are available at
http://www.hemscott.com/nsm.do or at the Company's registered
office.
Date Document
-------------- ----------------------------------------
13 April 2012 Annual Report and Accounts 2011
-------------- ----------------------------------------
13 April 2012 Notice of 2012 Annual General Meeting
-------------- ----------------------------------------
13 April 2012 Proxy forms for the 2012 Annual General
Meeting
-------------- ----------------------------------------
Documents filed with Companies House
The Company submitted filings to the Registrar of Companies in
England and Wales as detailed in the table below.
Date Filed Form Description
----------- ------ ----------------------------------------
12/11/2012 SH01 Statement of Capital GBP 19,697,811
----------- ------ ----------------------------------------
10/10/2012 SH01 Statement of Capital GBP 19,697,141
----------- ------ ----------------------------------------
07/09/2012 AR01 Annual Return, No Member List
----------- ------ ----------------------------------------
09/07/2012 SH01 Statement of Capital GBP 19,686,391
----------- ------ ----------------------------------------
15/06/2012 RES10 Authorised Allotment of Shares and
Debentures
----------- ------ ----------------------------------------
15/06/2012 AA Group of Companies' Accounts made up
to 31/12/11
----------- ------ ----------------------------------------
06/06/2012 SH01 Statement of Capital GBP 19,682,241
----------- ------ ----------------------------------------
21/05/2012 RES10 Authorised Allotment of Shares and
Debentures
----------- ------ ----------------------------------------
11/04/2012 AP03 Secretary Appointed, Peter Alexander
Speirs
----------- ------ ----------------------------------------
11/04/2012 TM02 Secretary Appointment Terminated, Henry
Knowles
----------- ------ ----------------------------------------
Copies of all these documents may be obtained from Companies
House, Crown Way, Maindy, Cardiff CF14 3UZ or, if you are a
registered user, they may be viewed and downloaded using Companies
House Direct at www.direct.companieshouse.gov.uk.
Further Information
Copies of all documents can be obtained from the Company at the
registered office which is located at 13 Hanover Square, London W1S
1HW.
Peter Speirs
Company Secretary
5 April 2013
- ENDS -
Enquiries:
Hikma Pharmaceuticals PLC
Peter Speirs
Company Secretary +44 20 7399 2670
About Hikma
Hikma Pharmaceuticals PLC is a fast growing pharmaceutical group
focused on developing, manufacturing and marketing a broad range of
both branded and non-branded generic and in-licensed products.
Hikma's operations are conducted through three businesses:
"Branded", "Injectables" and "Generics" based primarily in the
Middle East and North Africa ("MENA") region, where it is a market
leader, the United States and Europe. In 2012, Hikma achieved
revenues of $1,108.7 million and profit attributable to
shareholders of $100.3 million.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AIUBELFBXZFBBBB
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
